Corcept Therapeutics
CORT
#2078
Rank
A$13.65 B
Marketcap
A$129.63
Share price
1.71%
Change (1 day)
40.71%
Change (1 year)

Corcept Therapeutics (CORT) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$0.28 Billion

According to Corcept Therapeutics 's latest financial reports the company's total liabilities are A$0.28 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Corcept Therapeutics - Total liabilities on balance sheet (from 2003 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$0.25 B53.56%
2023-12-31A$0.16 B40.56%
2022-12-31A$0.11 B81.27%
2021-12-31A$66.13 M5.09%
2020-12-31A$62.93 M7.13%
2019-12-31A$58.74 M15.56%
2018-12-31A$50.83 M34.22%
2017-12-31A$37.87 M-0.27%
2016-12-31A$37.97 M-17.18%
2015-12-31A$45.85 M-1.29%
2014-12-31A$46.45 M-1.48%
2013-12-31A$47.15 M31.06%
2012-12-31A$35.97 M634%
2011-12-31A$4.9 M28.99%
2010-12-31A$3.8 M41.12%
2009-12-31A$2.69 M-33.76%
2008-12-31A$4.06 M18.07%
2007-12-31A$3.44 M-23.38%
2006-12-31A$4.49 M-7.73%
2005-12-31A$4.86 M106.59%
2004-12-31A$2.35 M-95.95%
2003-12-31A$58.19 M-25.04%
2002-12-31A$77.62 M2002.81%
2001-12-31A$3.69 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
A$170.93 B 59,125.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$117.86 B 40,738.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$94.14 B 32,521.48%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
A$137.12 B 47,412.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$174.08 B 60,219.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$116.88 B 40,399.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A$1.22 B 325.33%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
A$0.81 B 181.26%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$2.34 B 712.79%๐Ÿ‡บ๐Ÿ‡ธ USA